Wip1 Regulates the Immunomodulatory Effects of Murine Mesenchymal Stem Cells in Type 1 Diabetes Mellitus via Targeting IFN-α/BST2

The authors investigated the effects of wild-type p53-induce phosphatase 1 (Wip1) on regulating MSCs immunosuppressive capacities in type 1 diabetes mellitus mice.